Myleran Tablet, Film Coated
Product Images NDC 80725-620

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Myleran (NDC 80725-620). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Waylis Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structure (Myleran 1)

FDA Label Image

Waylis Logo (Myleran 2)

FDA Label Image

Carton (Myleran 4)

Carton (Myleran 4)
MYLERAN® is a drug that consists of 2mg tablets containing busulfan. It is essential to take the drug only with medical supervision and is not recommended to take in larger doses or for a longer time than directed by the physician. Periodic blood counts are needed to decide the accurate dose. The tablets should be stored at a controlled room temperature of 25°C and can be dispensed in tight containers. The package insert should be consulted for dosage and administration. The tablets are distributed by Waylis Therapeutics LLC, and are made in Germany.*
FDA Label Image

Label (Myleran 5)

Label (Myleran 5)
Storeat25° (77 evcursions 25 Tablets NDC 80725-620-25 See presoiing nformatio for permeteato 1510 I0°0 (6910 86F) Dosageand Aamiaton 5o USP Contrle Foom et Depes it ACEGEUUETE R e migiconyions Lot Contanet 25 G i ihe P Tablets ik under lge ot Ditby: Supervsion. Dot ke i g. Therefore, it is not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.